ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,517Medicare Part D Prescriptions Filled, Including Refills

Rank: 186 out of 780

$569K Total Retail Price of All Prescriptions

Rank: 251 out of 780

355 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 355 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 9,815 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 873 580 1 2
FUROSEMIDE 501 367 2 7
AMLODIPINE BESYLATE 441 333 3 4
TRIAMTERENE-HCTZ 431 304 4 37
OMEPRAZOLE 351 206 5 3
FOSINOPRIL SODIUM 349 220 6 112
HYDROCHLOROTHIAZIDE 312 243 7 10
METFORMIN HCL 310 212 8 8
CLONIDINE HCL 295 196 9 28
POTASSIUM CHLORIDE 284 217 10 11
LISINOPRIL 249 200 11 6
CARVEDILOL 231 187 12 14
CYCLOBENZAPRINE HCL 230 98 R 13 42
HYDRALAZINE HCL 215 157 14 54
PRAVASTATIN SODIUM 214 137 15 9
ALENDRONATE SODIUM 211 150 16 44
ATENOLOL 207 145 17 21
DILTIAZEM 24HR ER 190 131 18 179
WARFARIN SODIUM 166 123 19 24
JANUVIA 163 101 20 85
ATORVASTATIN CALCIUM 159 121 21 12
DONEPEZIL HCL 158 151 22 31
SULINDAC 145 95 23 268
IBUPROFEN 144 109 24 93
KLOR-CON M20 135 120 25 57
HYDROCODONE-ACETAMINOPHEN 131 99 S3 26 1
PANTOPRAZOLE SODIUM 125 104 27 25
CLOPIDOGREL 123 91 28 34
DILTIAZEM 24HR CD 122 90 29 138
METOPROLOL TARTRATE 120 76 30 19
ZOLPIDEM TARTRATE 119 94 31 17
CITALOPRAM HBR 119 97 31 23
LEVOTHYROXINE SODIUM 113 82 33 5
PLAVIX 108 85 34 45
NIFEDIPINE ER 105 86 35 115
ALLOPURINOL 104 93 36 29
VERAPAMIL ER 102 81 37 78
RANITIDINE HCL 94 78 38 39
MECLIZINE HCL 91 68 39 83
CRESTOR 89 75 40 32
NOVOLIN 70-30 81 51 41 164
QUETIAPINE FUMARATE 81 70 41 81
ISOSORBIDE DINITRATE 79 71 43 218
INSULIN SYRINGE 78 56 44 80
PHENYTOIN SODIUM EXTENDED 74 50 45 128
ADVAIR DISKUS 73 53 46 68
TRIAMTERENE-HYDROCHLOROTHIAZID 73 64 46 162
DIOVAN 71 63 48 55
LOSARTAN POTASSIUM 69 64 49 18
TAMSULOSIN HCL 68 68 50 36
DOXAZOSIN MESYLATE 67 55 51 97
NAMENDA 67 58 51 46
CARTIA XT 67 59 51 407
BUSPIRONE HCL 64 47 54 125
AMLODIPINE BESYLATE-BENAZEPRIL 62 46 55 50
AGGRENOX 62 46 55 233
HUMULIN 70-30 60 45 57 106
PROAIR HFA 59 28 58 62
RAMIPRIL 59 49 58 70
GLIPIZIDE ER 55 30 60 109
TRAMADOL HCL 55 43 60 15
SINGULAIR 55 25 60 73
NASONEX 54 20 63 254
FAMOTIDINE 53 53 64 86
RISPERIDONE 53 34 64 98
GLIMEPIRIDE 51 43 66 30
THEOPHYLLINE ANHYDROUS 50 50 67 185
PREDNISONE 50 47 67 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.